期刊文献+

蒿甲醚对人乳腺癌细胞的增殖抑制作用研究 被引量:2

The inhibitory effect of artemether on the proliferation of human breast cancer cells
原文传递
导出
摘要 目的研究蒿甲醚对人乳腺癌MDA-MB-231细胞增殖活性、凋亡的影响及其机制。方法利用浓度为0,2.5,5,10,20,40,80及160μmol/L的蒿甲醚孵育24h。利用CCK8法测定细胞增殖抑制率。然后用浓度为0、20、40及80μmol/L的蒿甲醚培养MDA-MB-231细胞24h,利用Annexin V-FITC/PI法检测细胞凋亡及细胞周期。最后利用Western blot法检测MDA-MB-231细胞活化caspase-3及8的表达水平。结果蒿甲醚使MDA-MB-231细胞的增殖活性受到显著抑制,同时随着浓度升高抑制作用增强。与对照组相比,蒿甲醚显著促进MDAMB-231细胞的凋亡并使细胞周期维持在G+M期,显著上调caspase-3及8的活化水平。结论蒿甲醚对人乳腺癌2MDA-MB-231细胞有潜在的治疗作用。 Objective To investigate the effect of artemether on the proliferation and apoptosis of human breast cancer cells and the possible mechanism. Methods MDA-MB-231 cells were treated with artemether at the concentrations of 0, 2.5, 5, 10, 20, 40, 80 and 160μmol/L for 24h. The cell proliferation was measured with CCK8 assay. The cellular apoptosis rate and cellular cycle were checked by Annexin V-FITC/PI method, the expression of caspase-3/8 was determined by Western blot. Results The proliferative activity of MDA-MB-231 ceils was inhibited by artemether significantly in a dose-dependent manner. Artemether promoted the apoptosis of MDA-MB-231 ceils significantly, and upregulated the expression levels of Caspase-3 and 8 in MDA-MB-231 cells in a dose-dependent manner. Conclusion Artemether has potential effect for the treatment of human breast cancer.
出处 《解剖科学进展》 CAS 2015年第3期229-232,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金资助项目(No.81171131)
关键词 蒿甲醚 乳腺癌 增殖 凋亡 caspase-3/8 artemether breast cancer proliferation apoptosis caspase-3/8
  • 相关文献

参考文献16

  • 1Kamugisha E, Jing S, Minde M, et al. Efficacy of artemether- lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north- western Tanzania[J]. Malar J, 2012, 11 (1): 58-63.
  • 2Nakase I, Lai H, Singh NP, et al. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation[J]. Int J Pharm, 2008, 354(1-2): 28-33.
  • 3Farsam V, Hassan ZM, Zavaran-Hosseini A, et al. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo[J], lnt Immunopharmacol,2011, 11(11): 1802-1808.
  • 4Hou J, Wang D, Zhang R, et al. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action[J]. Clin Cancer Res, 2008, 14(17): 5519-5530.
  • 5Alclntara DD, Ribeiro HF, Cardoso PC, et al. In vitro evaluation of the eytotoxic and genotoxic effects of arternether, an antimalarial drug, in a gastric cancer cell line(PG100)[J]. J Appl Toxicol, 2013, 33(2): 151-156.
  • 6Ding D, Wei S, Song Y, et al. Osthole exhibits anti-cancer property in rat glioma ceils through inhibiting PI3K/Akt and MAPK signaling pathways[J]. Cell Physiol Biochem, 2013, 32(6): 1751-1760.
  • 7Zhang J, Wang Z, Hu X, et al. Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer[J]. Int J Cancer, 2015, 136(1): 204-211.
  • 8Li Y, Wu YL. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives: what are the future perspectives[J]. Med Trop (Mars), 1998, 58(3 Suppl): 9-12.
  • 9Kokwaro GO. Use of Artemisinin (Qinghaosu) derivatives in the treatment of malaria[J]. Aft J Health Sci, 1998, 5(1): 8-11.
  • 10Kranz D, Boutros M. A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis[J]. EMBO J, 2014, 33(3): 181-197.

同被引文献28

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部